How should perioperative management be handled for a patient on mycophenolate mofetil who has sustained bilateral leg fractures requiring major surgery?

Perioperative Management of Mycophenolate Mofetil for Bilateral Leg Fracture Surgery

For this patient requiring urgent/emergent bilateral leg fracture surgery on mycophenolate mofetil, the management depends critically on whether they have severe SLE or non-severe SLE/other indication: withhold mycophenolate 1 week before surgery for non-severe disease, but continue through surgery if severe SLE with risk of organ damage. 1

Critical Decision Point: Assess Disease Severity and Surgical Urgency

The 2022 ACR/AAHKS guideline provides conditional recommendations specifically for mycophenolate mofetil perioperative management, though these were developed for elective arthroplasty 1. However, the principles apply to major orthopedic surgery with important modifications for urgency:

For Non-Severe SLE or Other Indications:

• Withhold mycophenolate mofetil 1 week prior to surgery 1
• This recommendation balances infection risk against disease flare
• The rationale: patients without severe disease can tolerate temporary withdrawal and be monitored closely postoperatively for flares 1
• Key caveat: This is a bilateral leg fracture requiring urgent surgery—you likely cannot wait 1 week

For Severe SLE (Active Nephritis, CNS Lupus, or Other Organ-Threatening Disease):

• Continue mycophenolate mofetil through surgery 1
• The concern for disease flares and permanent organ damage from medication withdrawal outweighs infection risk 1
• Consult rheumatology urgently regarding disease severity assessment

Practical Algorithm for This Emergency Case:

Step 1: Determine Disease Severity (Within Hours)

• Contact patient's rheumatologist immediately
• Severe SLE indicators: active nephritis, CNS involvement, vasculitis, severe cytopenias, recent major organ involvement
• If severe SLE → continue mycophenolate through surgery
• If non-severe or other indication → proceed to Step 2

Step 2: For Non-Severe Disease - Assess Surgical Timing

Since bilateral leg fractures typically require surgery within 24-48 hours for optimal outcomes 2:

• If surgery can be delayed 5-7 days safely (rare): Hold mycophenolate for 1 week preoperatively
• If surgery needed within 24-48 hours (typical):
  • Hold mycophenolate immediately upon decision for surgery
  • Accept that you'll have 1-2 days of drug washout rather than ideal 7 days
  • Proceed with surgery—delaying orthopedic trauma surgery for immunosuppression washout carries significant morbidity risk

Step 3: Infection Risk Mitigation

Regardless of whether mycophenolate is continued or held:

• Ensure meticulous surgical technique
• Consider extended perioperative antibiotics (discuss with infectious disease)
• Monitor closely for surgical site infection
• The FDA label notes bone marrow suppression risk—check CBC preoperatively 3

Step 4: Postoperative Restart Timing

Restart mycophenolate when the wound shows evidence of healing: sutures/staples removed, no significant swelling/erythema/drainage, no ongoing infection—typically around 14 days postoperatively 1

This is a firm recommendation across all patient types who had medication withheld 1.

Important Caveats and Pitfalls:

Neutropenia Risk: Check absolute neutrophil count preoperatively. If ANC < 1.3 × 10³/μL, interrupt or reduce mycophenolate dosing 3. This is critical as neutropenia increases infection risk substantially.

Thrombocytopenia: Mycophenolate can cause thrombocytopenia 4. Check platelet count preoperatively—if low, consider holding drug and transfusing platelets if needed for surgery.

Renal Function: If patient has severe chronic renal impairment (GFR < 25 mL/min/1.73 m²), doses > 1g twice daily should be avoided 3. However, for emergency surgery, focus on infection prevention rather than dose adjustment.

Glucocorticoids: If patient is also on steroids for their rheumatic condition, continue their usual daily dose rather than stress-dose steroids 1. The evidence does not support supraphysiologic dosing.

Disease Flare Monitoring: Patients with difficult-to-control disease or frequent flares may warrant continuing medication even in non-severe cases—this requires shared decision-making with rheumatology 1.

The Reality of Emergency Surgery:

The guideline evidence is based on elective arthroplasty where timing is controllable 1. For bilateral leg fractures, delaying surgery beyond 48 hours to achieve optimal immunosuppression washout causes more harm (malunion, nonunion, immobility complications, pain) than proceeding with suboptimal drug timing. The orthopedic urgency supersedes the immunosuppression timeline unless the patient has severe SLE at risk for life-threatening flare.